Use of phosphonates for the treatment of osteoporosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/675 (2006.01) A61K 31/66 (2006.01) C07F 9/58 (2006.01) C07F 9/59 (2006.01)

Patent

CA 2138367

The use of a high potency phosphonate for increasing bone mass in a human or other mammal subject afflicted with osteoporosis, wherein the high potency phosphonate is used in a thirty day program in an amount of from 0.00001 mg P/kg to 0.1 mg P/kg of the subject per day for at least one day of the thirty day program, followed if required by a rest period of at least one day at the end of the thiry day program.

Utilisation d'un phosphonate à grande puissance pour l'accroissement de la masse osseuse chez les humains ou chez d'autres mammifères souffrant d'ostéoporose, dans le cadre d'un programme d'administration de trente jours à raison de 0,00001 à 0,1 mg P/kg de masse corporelle du sujet par jour pendant au moins un des trente jours du programme, avec au besoin une période de repos d'au moins un jour à la fin du programme de trente jours.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of phosphonates for the treatment of osteoporosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of phosphonates for the treatment of osteoporosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phosphonates for the treatment of osteoporosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1936248

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.